Evidence map›Paper›PMID 18446227›Full record

ArticlePloS one2008

Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells.

Jing-xin Zhang, Gretchen E Diehl, Dan R Littman

Abstract read
In one paragraph

Article in PloS one, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Absence of cGAS-mediated type I IFN responses in HIV-1-infected T cells.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  5. The wide utility of rabbits as models of human diseases.Experimental & molecular medicine · 2018
    Review
  6. Article
  7. Article
  8. Article
  9. Mouse knockout models for HIV-1 restriction factors.Cellular and molecular life sciences : CMLS · 2014
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jing-xin ZhangThe Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, New York, United States of America.
Gretchen E Diehl
Dan R Littman

Funding

MURINE MODEL SYSTEM FOR HIV PATHOGENESISR01AI033856 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI LITTMAN, DAN · 1993 to 2008
$4.2M
CELLULAR FACTORS REQUIRED FOR HIV ENTRYR37AI033303 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI LITTMAN, DAN · 1998 to 2007
$3.3M
CELLULAR FACTORS REQUIRED FOR HIV ENTRYR01AI033303 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI LITTMAN, DAN R · 1993 to 1997
–
NIAID NIH HHS AI033303NIAID NIH HHS AI033856NIAID NIH HHS R01 AI033856NIAID NIH HHS R37 AI033303
6 · The paper itself

Abstract

Development of a small animal model to study HIV replication and pathogenesis has been hampered by the failure of the virus to replicate in non-primate cells. Most studies aimed at achieving replication in murine cells have been limited to fibroblast cell lines, but generating an appropriate model requires overcoming blocks to viral replication in primary T cells. We have studied HIV-1 replication in CD4(+) T cells from human CD4/CCR5/Cyclin T1 transgenic mice. Expression of hCD4 and hCCR5 in mouse CD4(+) T cells enabled efficient entry of R5 strain HIV-1. In mouse T cells, HIV-1 underwent reverse transcription and nuclear import as efficiently as in human T cells. In contrast, chromosomal integration of HIV-1 proviral DNA was inefficient in activated mouse T cells. This process was greatly enhanced by providing a secondary T cell receptor (TCR) signal after HIV-1 infection, especially between 12 to 24 h post infection. This effect was specific for primary mouse T cells. The pathways involved in HIV replication appear to be PKCtheta-, CARMA1-, and WASp-independent. Treatment with Cyclosporin A (CsA) further relieved the pre-integration block. However, transcription of HIV-1 RNA was still reduced in mouse CD4(+) T cells despite expression of the hCyclin T1 transgene. Additional post-transcriptional defects were observed at the levels of Gag expression, Gag processing, Gag release and virus infectivity. Together, these post-integration defects resulted in a dramatically reduced yield of infectious virus (300-500 fold) after a single cycle of HIV-1 replication. This study implies the existence of host factors, in addition to those already identified, that are critical for HIV-1 replication in mouse cells. This study also highlights the differences between primary T cells and cell lines regarding pre-integration steps in the HIV-1 replication cycle.

Indexed as

Virus IntegrationVirus ReplicationActive Transport, Cell NucleusAnimalsCD4 AntigensCell NucleusCells, CulturedCyclinsCyclin TCyclosporineHIV-1HIV InfectionsHIV Long Terminal RepeatHumansMiceMice, TransgenicCCNT1 protein, humanCD4 AntigensCyclinsCyclin TCyclosporineReceptors, Antigen, T-CellReceptors, CCR5

Identifiers

PMID18446227
PMCPMC2323578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.